866-997-4948(US-Canada Toll Free)

Veterinary Drugs Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024

Published By :

Transparency

Published Date : Mar 2017

Category :

Pharmaceutical

No. of Pages : 155 Pages

Global Veterinary Drug Market: Overview

This report on the veterinary drugs market analyzes the current and future scenario of the global market. Increase in pet ownership, rise in healthcare expenditure on companion animals, rise in meat consumptions along with high demand for good quality proteins are some of the drivers expected to drive the global veterinary drugs market during the forecast period.

The global veterinary drugs market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the countrys market with respect to the segments based on product type, animal type, route of administration and regions. A detailed qualitative analysis of drivers and restraints, opportunities, and trends has been provided in the market overview section. Additionally, the section comprises Porters Five Forces Analysis to help understand the competitive landscape in the market. This section also provides market attractiveness analysis in terms of country and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global veterinary drugs market.

Global Veterinary Drug Market: Key Market Segments

Based on product type, the market has been segmented into anti-infective, anti-inflammatory, parasiticides, and others. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference from veterinarians for treating the animals with various drug classes. The market size and forecast for each of these segments have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Based on animals, the global veterinary drugs market has been segmented into companion animals and livestock animals. The market segments have been extensively analyzed based on increase in demand for disease treatment among companion animals and livestock animals. Increase in pet ownership, demand for infection free meat, and increase in awareness for treatment of the domesticated animals are driving the market share of animal segment. Different types of route of administration are used to feed the drug to animals. On basis of route of administration global veterinary drugs market is segmented into oral, parenteral, and topical route of administration. Under the route of administration segment, oral administration of drugs in animals plays a major role followed by parenteral. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2014 to 2024. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2016 to 2024, considering 2015 as the base year.

Global Veterinary Drugs Market: Regional Outlook

Geographically, the global veterinary drugs market on the basis of region has been segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa. The market size and forecast for each of these regions have been provided for the period from 2014 to 2024, along with their respective CAGRs for the forecast period from 2016 to 2024, considering 2015 as the base year.

Companies Mentioned in Report

The report also profiles major players in the global veterinary drugs market based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include players in the global veterinary drugs market are Bayer AG., Boehringer Ingelheim GmbH, Ceva Sant Animale, Dechra Pharmaceuticals PLC., Elanco Animal Health (Eli Lilly and Company), Merck & Co., Inc., Virbac, Vetoquinol, Zoetis, Inc. and others.

The Global Veterinary Drugs Market has been segmented as follows:

Global Veterinary Drugs Market, by Product

  • Anti-infective
  • Anti-inflammatory
  • Parasiticides
  • Others

Global Veterinary Drugs Market, by Animal

  • Companion
  • Livestock

Global Veterinary Drugs Market, by Route of Distribution

  • Oral
  • Parenteral
  • Topical

Global Veterinary Drugs Market, by Geography

  • North America
  • US
  • Canada
  • Europe
  • Germany
  • U.K.
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
  • Japan
  • India
  • China
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Latin America
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • GCC countries
  • South Africa
  • Rest of Middle East & Africa

Table of Content

Chapter 1. Preface
1.1. Report Scope and Market Segmentation
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary
3.1. Global Veterinary Drugs Market : Snapshot, 2015
3.2. Global Veterinary Drugs Market : Opportunity Map

Chapter 4. Market Overview
4.1. Product Overview
4.2. Global Veterinary Drugs Market Size (US$ Mn) Forecast, 20142024
4.3. Global Veterinary Drugs Market Outlook
4.4. Global Veterinary Drugs Market : Key Industry Events
4.5. Global Veterinary Drugs Market : Porter's Analysis
4.6. Key Product Opportunities

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
5.2.1. Increase in pet ownership & spending on companion animals
5.2.2. Increased medical and surgical capabilities for companion animals
5.2.3. Greater emphasis on prevention and wellness by veterinarians and owners
5.2.4. Evolution of new products to combat emergence of new diseases particularly to cope with zoonotic disease concerns
5.2.5. Increased meat consumption and demand for high quality proteins driving demand for livestock animals
5.3. Restraints
5.3.1. Lack of novel veterinary drugs in the global market
5.3.2. Rising concern about the use of antibiotics and growth promoters in food animals
5.3.3. Prevalence of counterfeit medicines
5.4. Global Veterinary Drugs Market : Opportunity Analysis
5.5. Opportunities
5.5.1. Biologics and specialty care offer potential opportunities for players
5.5.2. Growing awareness and affordability of drugs for pets and livestock offer significant opportunity to new entrants
5.6. Key Trends
5.6.1. Launch of generic versions of veterinary drugs by prominent players
5.6.2. Increase in pet insurance globally
5.6.3. Targeted in-licensing and strategic acquisitions by leading players
5.6.4. Viral disease outbreak demands newer medicines every time

Chapter 6. Veterinary Drugs Market Analysis, by Product Type
6.1. Key Findings
6.2. Introduction
6.3. Global Veterinary Drugs Market Value Share Analysis, by Product Type
6.4. Veterinary Drugs Market Analysis, by Product Type
6.4.1. Anti-infective
6.4.2. Anti-inflammatory
6.4.3. Parasiticides
6.4.4. Others
6.5. Market Attractiveness Analysis, by Product Type
6.6. Key Trends

Chapter 7. Veterinary Drugs Market Analysis, by Animal Type
7.1. Key Findings
7.2. Introduction
7.3. Global Veterinary Drugs Market Value Share Analysis, by Animal Type
7.4. Veterinary Drugs Market Analysis, by Animal Type
7.4.1. Companion
7.4.2. Livestock
7.5. Market Attractiveness Analysis, by Animal Type
7.6. Key Trends

Chapter 8. Veterinary Drugs Market Analysis, by Route of Administration
8.1. Key Findings
8.2. Introduction
8.3. Global Veterinary Drugs Market Value Share Analysis, by Route of Administration
8.4. Veterinary Drugs Market Analysis, by Route of Administration
8.4.1. Oral
8.4.2. Parenteral
8.4.3. Topical
8.5. Market Attractiveness Analysis, by Route of Administration
8.6. Key Trends

Chapter 9. Veterinary Drugs Market Analysis, by Region
9.1. Global Veterinary Drugs Market Snapshot, by Country
9.2. Global Veterinary Drugs Market Value Share Analysis, by Region
9.3. Veterinary Drugs Market Forecast, by Region
9.4. Market Attractiveness Analysis, by Region

Chapter 10. North America Veterinary Drugs Market Analysis
10.1. Key Findings
10.2. Market Overview
10.3. Market Analysis, by Product
10.3.1. Market Value Share Analysis, by Product
10.3.2. Market Size (US$ Mn) Forecast, by Product
10.3.2.1. Anti-infective
10.3.2.2. Anti-inflammatory
10.3.2.3. Parasiticides
10.3.2.4. Others
10.4. Market Analysis, by Animal
10.4.1. Market Value Share Analysis, by Animal
10.4.2. Market Size (US$ Mn) Forecast, by Animal
10.4.2.1. Companion
10.4.2.2. Livestock
10.5. Market Analysis, by Route of Administration
10.5.1. Market Value Share Analysis, by Route of Administration
10.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
10.5.2.1. Oral
10.5.2.2. Parenteral
10.5.2.3. Topical
10.6. Market Analysis, by Country
10.6.1. Market Value Share Analysis, by Country
10.6.2. Market Size (US$ Mn) Forecast, by Country, 20162024
10.6.2.1. U.S.
10.6.2.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. by Product
10.7.2. by Animal
10.7.3. by Route of Administration
10.7.4. by Country
10.8. Market Trends

Chapter 11. Europe Veterinary Drugs Market Analysis
11.1. Key Findings
11.2. Market Overview
11.3. Market Analysis, by Product
11.3.1. Market Value Share Analysis, by Product
11.3.2. Market Size (US$ Mn) Forecast, by Product
11.3.2.1. Anti-infective
11.3.2.2. Anti-inflammatory
11.3.2.3. Parasiticides
11.3.2.4. Others
11.4. Market Analysis, by Animal
11.4.1. Market Value Share Analysis, by Animal
11.4.2. Market Size (US$ Mn) Forecast, by Animal
11.4.2.1. Companion
11.4.2.2. Livestock
11.5. Market Analysis, by Route of Administration
11.5.1. Market Value Share Analysis, by Route of Administration
11.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
11.5.2.1. Oral
11.5.2.2. Parenteral
11.5.2.3. Topical
11.6. Market Analysis, by Country
11.6.1. Market Value Share Analysis, by Country
11.6.2. Market Size (US$ Mn) Forecast, by Country, 20162024
11.6.2.1. U.K.
11.6.2.2. Germany
11.6.2.3. Italy
11.6.2.4. France
11.6.2.5. Spain
11.6.2.6. Russia
11.6.2.7. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. by Product
11.7.2. by Animal
11.7.3. by Route of Administration
11.7.4. by Country
11.8. Market Trends

Chapter 12. Asia Pacific Veterinary Drugs Market Analysis
12.1. Key Findings
12.2. Market Overview
12.3. Market Analysis, by Product
12.3.1. Market Value Share Analysis, by Product
12.3.2. Market Size (US$ Mn) Forecast, by Product
12.3.2.1. Anti-infective
12.3.2.2. Anti-inflammatory
12.3.2.3. Parasiticides
12.3.2.4. Others
12.4. Market Analysis, by Animal
12.4.1. Market Value Share Analysis, by Animal
12.4.2. Market Size (US$ Mn) Forecast, by Animal
12.4.2.1. Companion
12.4.2.2. Livestock
12.5. Market Analysis, by Route of Administration
12.5.1. Market Value Share Analysis, by Route of Administration
12.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
12.5.2.1. Oral
12.5.2.2. Parenteral
12.5.2.3. Topical
12.6. Market Analysis, by Country
12.6.1. Market Value Share Analysis, by Country
12.6.2. Market Size (US$ Mn) Forecast, by Country, 20162024
12.6.2.1. China
12.6.2.2. Japan
12.6.2.3. India
12.6.2.4. Australia & New Zealand
12.6.2.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. by Product
12.7.2. by Animal
12.7.3. by Route of Administration
12.7.4. by Country
12.8. Market Trends

Chapter 13. Latin America Veterinary Drugs Market Analysis
13.1. Key Findings
13.2. Market Overview
13.3. Market Analysis, by Product
13.3.1. Market Value Share Analysis, by Product
13.3.2. Market Size (US$ Mn) Forecast, by Product
13.3.2.1. Anti-infective
13.3.2.2. Anti-inflammatory
13.3.2.3. Parasiticides
13.3.2.4. Others
13.4. Market Analysis, by Animal
13.4.1. Market Value Share Analysis, by Animal
13.4.2. Market Size (US$ Mn) Forecast, by Animal
13.4.2.1. Companion
13.4.2.2. Livestock
13.5. Market Analysis, by Route of Administration
13.5.1. Market Value Share Analysis, by Route of Administration
13.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
13.5.2.1. Oral
13.5.2.2. Parenteral
13.5.2.3. Topical
13.6. Market Analysis, by Country
13.6.1. Market Value Share Analysis, by Country
13.6.2. Market Size (US$ Mn) Forecast, by Country, 20162024
13.6.2.1. Brazil
13.6.2.2. Mexico
13.6.2.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. by Product
13.7.2. by Animal
13.7.3. by Route of Administration
13.7.4. by Country
13.8. Market Trends

Chapter 14. Middle East & Africa Veterinary Drugs Market Analysis
14.1. Key Findings
14.2. Market Overview
14.3. Market Analysis, by Product
14.3.1. Market Value Share Analysis, by Product
14.3.2. Market Size (US$ Mn) Forecast, by Product
14.3.2.1. Anti-infective
14.3.2.2. Anti-inflammatory
14.3.2.3. Parasiticides
14.3.2.4. Others
14.4. Market Analysis, by Animal
14.4.1. Market Value Share Analysis, by Animal
14.4.2. Market Size (US$ Mn) Forecast, by Animal
14.4.2.1. Companion
14.4.2.2. Livestock
14.5. Market Analysis, by Route of Administration
14.5.1. Market Value Share Analysis, by Route of Administration
14.5.2. Market Size (US$ Mn) Forecast, by Route of Administration
14.5.2.1. Oral
14.5.2.2. Parenteral
14.5.2.3. Topical
14.6. Market Analysis, by Country
14.6.1. Market Value Share Analysis, by Country
14.6.2. Market Size (US$ Mn) Forecast, by Country, 20162024
14.6.2.1. GCC Countries
14.6.2.2. South Africa
14.6.2.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. by Product
14.7.2. by Animal
14.7.3. by Route of Administration
14.7.4. by Country
14.8. Market Trends

Chapter 15. Company Profiles
15.1. Veterinary Drugs Market Share Analysis, by Company, 2016 (Estimated)
15.2. Competition Matrix
15.3. Company Profiles
15.3.1. Bayer AG
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Financial Overview
15.3.1.3. Product Portfolio
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Boehringer Ingelheim GmbH
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Financial Overview
15.3.2.3. Product Portfolio
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Ceva Sant Animale
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Financial Overview
15.3.3.3. Product Portfolio
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. Dechra Pharmaceuticals PLC
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Financial Overview
15.3.4.3. Product Portfolio
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. Eli Lilly and Company (Elanco Animal Health)
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Financial Overview
15.3.5.3. Product Portfolio
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Merck Animal Health
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Financial Overview
15.3.6.3. Product Portfolio
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Virbac
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Financial Overview
15.3.7.3. Product Portfolio
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. Vetoquinol S.A.
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Financial Overview
15.3.8.3. Product Portfolio
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Zoetis, Inc.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Financial Overview
15.3.9.3. Product Portfolio
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview

List of Table


Table 1: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Product Type, 20142024
Table 2: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type Type, 20142024
Table 3: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 20142024
Table 4: Global Veterinary Drugs Market Size (US$ Mn) Forecast, by Region, 20142024
Table 5: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 20142024
Table 6: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 20142024
Table 7: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 20142024
Table 8: North America Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 20142024
Table 9: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 20142024
Table 10: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 20142024
Table 11: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 20142024
Table 12: Europe Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 20142024
Table 13: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 20142024
Table 14: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 20142024
Table 15: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 20142024
Table 16: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 20142024
Table 17: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 20142024
Table 18: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 20142024
Table 19: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 20142024
Table 20: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 20142024
Table 21: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Product, 20142024
Table 22: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Animal Type, 20142024
Table 23: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 20142024
Table 24: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast, by Country, 20142024

List of Chart

Figure 1: Global Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 20142024
Figure 2: Global Veterinary Drugs Market Value Share, by Product Type, 2016 and 2024
Figure 3: Global Anti-infective Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 4: Global Anti-inflammatory Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 5: Global Parasiticides Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 6: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 7: Global Veterinary Drugs Market Attractiveness Analysis, by Product Type, 20162024
Figure 8: Global Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 9: Global Companion Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 10: Global Livestock Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 11: Global Veterinary Drugs Market Attractiveness Analysis, by Animal Type, 20162024
Figure 12: Global Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 13: Global Oral Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 14: Global Parenteral Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 15: Global Topical Route of Administration Market Revenue (US$ Mn) and Y-o-Y Growth (%), 20142024
Figure 16: Global Veterinary Drugs Market Attractiveness Analysis, by Route of Administration, 20162024
Figure 17: Global Veterinary Drugs Market Value Share, by Region, 2016 and 2024
Figure 18: Global Veterinary Drugs Market Attractiveness Analysis, by Region, 20162024
Figure 19: North America Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 20162024
Figure 20: North America Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 21: North America Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 22: North America Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 23: North America Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 24: North America Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 25: North America Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 26: North America Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 27: North America Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 28: Europe Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 20162024
Figure 29: Europe Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 30: Europe Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 31: Europe Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 32: Europe Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 33: Europe Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 34: Europe Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 35: Europe Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 36: Europe Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 37: Asia Pacific Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 20162024
Figure 38: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 39: Asia Pacific Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 40: Asia Pacific Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 41: Asia Pacific Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 42: Asia Pacific Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 43: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 44: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 45: Asia Pacific Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 46: Latin America Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 20162024
Figure 47: Latin America Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 48: Latin America Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 49: Latin America Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 50: Latin America Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 51: Latin America Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 52: Latin America Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 53: Latin America Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 54: Latin America Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 55: Middle East & Africa Veterinary Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 20162024
Figure 56: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Country
Figure 57: Middle East & Africa Veterinary Drugs Market Value Share, by Product, 2016 and 2024
Figure 58: Middle East & Africa Veterinary Drugs Market Value Share, by Animal Type, 2016 and 2024
Figure 59: Middle East & Africa Veterinary Drugs Market Value Share, by Route of Administration, 2016 and 2024
Figure 60: Middle East & Africa Veterinary Drugs Market Value Share Analysis, by Country, 2016 and 2024
Figure 61: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Product
Figure 62: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Animal Type
Figure 63: Middle East & Africa Veterinary Drugs Market Attractiveness Analysis, by Route of Administration
Figure 64: Global Veterinary Drugs Market Share Analysis, by Company, 2016 (Estimated)

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *